Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking Wegovy experience some side effects, particularly in the early weeks of treatment. Nausea is the most commonly reported, but fatigue, digestive changes and headaches also feature. The good news is that for most people these settle within a few days to a couple of weeks, and there are practical steps that genuinely help. Wegovy (semaglutide) is a prescription-only medicine, so how you manage side effects should always be discussed with your prescribing clinician rather than adjusted on your own — the guidance below explains what the evidence supports and, critically, what should prompt you to seek medical attention promptly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors in the gut and brain, which slows how quickly your stomach empties and dampens appetite signals. That slowing effect is part of what makes Wegovy effective for weight management, but it's also why nausea and digestive symptoms are so common early on. Your gut is adapting to a new environment, and that takes time.
Side effects tend to cluster around two moments: the very first dose, and each dose increase on the titration schedule. In the STEP 1 trial, gastrointestinal symptoms were reported by a significant proportion of participants, but the majority described them as mild to moderate and transient. The NHS semaglutide medicines page confirms this pattern and lists the most common effects as nausea, vomiting, diarrhoea, constipation, stomach pain, indigestion, burping and fatigue.
Headaches and dizziness also appear on the list. These are less predictable in timing but often linked to reduced food intake in the first few days. Injection-site reactions (a patch of redness or mild irritation where you inject) are relatively common too, and rotating the site between the abdomen, thigh and upper arm helps reduce them.
Knowing that a surge in symptoms around a dose change is expected, not a sign something has gone wrong, is often the most useful thing our prescribers can tell a patient who calls us in week two. For detailed guidance on helping ease nausea specifically, our page on how to help nausea with Wegovy covers practical strategies in more depth.
There's no single fix, but the evidence and clinical experience point to a consistent set of habits that reduce how much the GI side effects intrude on daily life.
Eat smaller meals, more slowly. A full stomach amplifies the delayed-emptying effect; a smaller one gives less for the gut to work through at once. Fatty, fried and very rich foods are the biggest triggers for nausea, so a temporarily blander diet (not permanently restrictive) helps many people through the first few weeks. Keeping well hydrated is important too, particularly if you are experiencing loose stools, because dehydration can compound fatigue and headaches.
Timing matters with injection day. Some people find injecting in the evening means the peak of nausea, if it comes, arrives overnight. Others prefer morning. Neither is clinically mandated; the SmPC requires once weekly, same day each week, and beyond that you can work with what suits your routine.
Alcohol is worth cutting back on during titration, it compounds nausea and can irritate the stomach. Carbonated drinks can worsen burping and bloating.
Our page on how to minimise Wegovy side effects goes into further detail, including how protein intake and gentle activity fit into the picture. If you are already on treatment and finding the adjustment harder than expected, there's also a broader look at dealing with Wegovy side effects that covers what to do if symptoms persist beyond the first couple of weeks.
Most of the time, discomfort settles and the practical steps above are enough. But some symptoms are signals to stop self-managing and get professional help quickly.
Seek urgent medical attention if you experience severe stomach pain, especially if it radiates toward your back, with or without vomiting. This symptom pattern can indicate acute pancreatitis. The MHRA's Drug Safety Update from January 2026 reinforced that while pancreatitis is infrequent, it can be serious, and the key to limiting harm is acting fast, not waiting to see if it passes.
Other symptoms that warrant prompt medical contact: signs of a severe allergic reaction (swelling of the face, throat or tongue, difficulty breathing, rapid heartbeat), symptoms of significant dehydration from vomiting or diarrhoea (very dark urine, dizziness on standing, inability to keep fluids down), and gallbladder-type pain, a sharp, cramping pain in the upper right abdomen that may radiate to the shoulder. Gallbladder problems are a known side effect of rapid weight loss and GLP-1 use. Our page covering Wegovy side effects in full includes more detail on which symptoms to watch for and how they are categorised by frequency.
If you notice changes in mood, low spirits or thoughts of self-harm after starting Wegovy, contact your GP or prescriber the same day. This is not a commonly reported effect but it is listed in the prescribing information and should never be dismissed.
You can also report any suspected side effect directly to the MHRA at yellowcard.mhra.gov.uk. This isn't only for serious reactions, even mild, unexpected effects are useful for regulators to know about, and patients can submit reports themselves.
If you are with nume and have a concern about a symptom, our aftercare team is available seven days a week. You can reach us via our contact page.
Side effects that don't improve after two to three weeks at a dose, or that are severe enough to affect eating, sleeping or daily function, are a reason to contact your prescribing clinician rather than push through. Staying at a lower dose for longer than the standard schedule is a legitimate clinical option and one that many prescribers use to reduce the burden of GI symptoms; it's not a step backwards. If you want practical advice on easing that burden, our guide on how to help semaglutide side effects brings together the most effective approaches in one place.
It's also worth raising side effects at your next clinical review rather than waiting to be asked. At nume, every repeat order involves a clinical re-review, your answers to those check-in questions are read by a real prescriber, not processed by software, and changes to the plan can be made at that point. Side-effect patterns are part of what that review is for.
For a broader picture of what the full Wegovy treatment journey involves, our Wegovy treatment overview sets out how the dose schedule works, what the licence covers and who the treatment is suitable for. Our prescribers discuss both suitability and the likely side-effect profile as part of every consultation, if you haven't started yet, starting your free consultation is the first step to getting that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.